Pacifica Partners’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.51K Hold
375
﹤0.01% 351
2026
Q1
$3.45K Hold
375
﹤0.01% 376
2025
Q4
$2.71K Hold
375
﹤0.01% 382
2025
Q3
$2.6K Hold
375
﹤0.01% 444
2025
Q2
$2.6K Hold
375
﹤0.01% 455
2025
Q1
$2.64K Hold
375
﹤0.01% 431
2024
Q4
$3.04K Hold
375
﹤0.01% 407
2024
Q3
$2.75K Hold
375
﹤0.01% 440
2024
Q2
$2.47K Hold
375
﹤0.01% 457
2024
Q1
$3.4K Hold
375
﹤0.01% 437
2023
Q4
$2.91K Hold
375
﹤0.01% 471
2023
Q3
$2.52K Hold
375
﹤0.01% 460
2023
Q2
$3.52K Hold
375
﹤0.01% 399
2023
Q1
$3.61K Hold
375
﹤0.01% 412
2022
Q4
$2.69K Hold
375
﹤0.01% 407
2022
Q3
$2K Hold
375
﹤0.01% 448
2022
Q2
$2K Hold
375
﹤0.01% 454
2022
Q1
$1K Hold
375
﹤0.01% 477
2021
Q4
$2K Hold
375
﹤0.01% 448
2021
Q3
$2K Hold
375
﹤0.01% 454
2021
Q2
$3K Sell
375
-125
-25% -$1.08K ﹤0.01% 404
2021
Q1
$5K Hold
500
﹤0.01% 329
2020
Q4
$4K Hold
500
﹤0.01% 317
2020
Q3
$4K Hold
500
﹤0.01% 288
2020
Q2
$5K Hold
500
0.01% 303
2020
Q1
$3K Hold
500
﹤0.01% 317
2019
Q4
$3K Buy
+500
New +$3.47K ﹤0.01% 319

Other funds holding VMD

Pacifica Partners's VMD Position: Q2 2026 in Review

Pacifica Partners held its Viemed Healthcare (VMD) position steady in Q2 2026 at 375 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

Pacifica Partners first reported a position in VMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $5K in Q1 2021. 15 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Pacifica Partners held 375 shares of Viemed Healthcare worth $4.51K as of Q2 2026.
  • Pacifica Partners left its Viemed Healthcare share count unchanged in Q2 2026.
  • Viemed Healthcare made up ﹤0.01% of Pacifica Partners's portfolio in Q2 2026, its #351 holding.
  • Pacifica Partners first reported a position in Viemed Healthcare in Q4 2019 and has held it in 27 quarters since.
  • Pacifica Partners's Viemed Healthcare position peaked at $5K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.